Androgenic therapy for advanced breast cancer in women. A report of the cooperative breast cancer group.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000731:Androstanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007664:Ketosteroids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013738:Testolactone / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D000731:Androstanes; D007664:Ketosteroids; D013738:Testolactone